The QIAstat-Dx Analyzer, combined with QIAstat-Dx assay cartridges, uses real-time PCR to detect pathogen nucleic acids in human biological samples. The QIAstat-Dx Analyzer and cartridges are designed as a closed system that contains on board all necessary reagents, enabling hands-off sample preparation. Detected real-time amplification signals are interpreted by the integrated software and are reported via an intuitive user interface.
Available panels utilize powerful QIAGEN sample and assay technologies, to deliver true Sample to Insight processing of even the most challenging samples.
QIAstat-Dx Respiratory SARS-CoV-2 Panel: This expanded version of our multiplex respiratory cartridge detects and differentiates 22 viral and bacterial respiratory targets*, including SARS-CoV-2 to support efforts to provide accessible testing to meet the demands of the COVID-19 outbreak.
*Enterovirus and Rhinovirus are both detected, but not differentiated, with the QIAstat-Dx Respiratory SARS-CoV-2 Panel.
QIAstat-Dx SARS-CoV-2/Flu A/B/RSV Panel: Qualitative test to analyze 4 targets for common respiratory pathogens, including SARS-CoV-2, to support efforts to provide accessible testing to meet the demands of the COVID-19 outbreak.
QIAstat-Dx Gastrointestinal Panel: Qualitative test to analyze 24 targets for common pathogens causing gastrointestinal infections.
QIAstat-Dx Gastrointestinal Panel 2: Qualitative test to analyze 22 targets for common pathogens causing gastrointestinal infections, including differentiation of Shiga-like toxin producing E. coli (STEC) stx1 and stx2*.
*Toxin content of STEC (stx1 and/or stx2) is reported separately by the QIAstat-Dx Gastrointestinal Panel 2
QIAstat-Dx Meningitis/Encephalitis Panel: Qualitative test to analyze 15 targets for common pathogens causing central nervous system infections (meningitis and encephalitis).